B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by B Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q2 2026 holdings
- Shares (Q2 2026)
- 135,000
- Value
- $4.51M
- % of portfolio
- 2.6%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 135,000 | $4.51M | 2.6% | 00.0% | Unchanged | Holders |
| Q1 2026 | 135,000 | $2.83M | 2.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 135,000 | $3.10M | 2.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 135,000 | $4.06M | 3.9% | +25,000+22.7% | Added | Holders |
| Q2 2025 | 110,000 | $4.00M | 3.5% | +62,500+131.6% | Added | Holders |
| Q1 2025 | 47,500 | $1.72M | 1.5% | +39,904+525.3% | Added | Holders |
| Q4 2024 | 7,596 | $319.6K | 0.2% | – | No prior filing | Holders |